{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:10:03Z","timestamp":1784837403820,"version":"3.55.0"},"reference-count":237,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Epilepsy is a chronic neurological disorder affecting nearly 50 million people worldwide and is characterized by recurrent seizures caused by abnormal neuronal activity. Conventional therapies, including antiepileptic drugs, growth factors, and gene therapy, are often limited by poor blood-brain barrier (BBB) penetration, drug resistance, adverse effects, and low bioavailability. This review summarizes recent advances in nanocarrier-based drug delivery systems for improving epilepsy treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive review of peer-reviewed articles, patents, and clinical studies was conducted to evaluate lipid-based, vesicular, polymeric, dendrimer, and inorganic nanocarriers. Their formulation strategies, BBB transport mechanisms, therapeutic applications, clinical progress, and future prospects were critically analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Nanocarriers enhance the solubility, stability, bioavailability, controlled release, and brain targeting of antiepileptic drugs. Liposomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, dendrimers, nanoemulsions, and metallic nanoparticles have demonstrated improved BBB penetration, prolonged drug action, reduced toxicity, and enhanced seizure control in preclinical studies. Despite promising outcomes, challenges related to large-scale manufacturing, long-term safety, regulatory approval, and clinical translation remain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nanomedicine represents a promising approach for overcoming the limitations of conventional epilepsy therapy by enabling efficient brain-targeted drug delivery. Further optimization, safety evaluation, and clinical validation are essential to support the successful translation of nanocarrier-based therapies into clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgag077","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:34:44Z","timestamp":1784835284000},"source":"Crossref","is-referenced-by-count":0,"title":["Nanocarrier-based targeting strategies in epilepsy: addressing pathophysiological barriers"],"prefix":"10.1093","volume":"78","author":[{"given":"Abhishek","family":"Chauhan","sequence":"first","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University , Rajpura, Punjab 140401 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Kumar","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University , Rajpura, Punjab 140401 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3266-7649","authenticated-orcid":false,"given":"Ankit","family":"Awasthi","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University , Rajpura, Punjab 140401 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-8749","authenticated-orcid":false,"given":"Rohit","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University , Rajpura, Punjab 140401 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026072315343652000_ref1","first-page":"392","article-title":"Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"P T"},{"key":"2026072315343652000_ref2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026072315343652000_ref3","volume-title":"Epilepsy"},{"key":"2026072315343652000_ref4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/epi.17165","article-title":"The global cost of epilepsy: a systematic review and extrapolation","volume":"63","author":"Begley","year":"2022","journal-title":"Epilepsia"},{"key":"2026072315343652000_ref5","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2147\/NDT.S256699","article-title":"Clinical management of drug resistant epilepsy: a review on current strategies","volume":"17","author":"Guery","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2026072315343652000_ref6","volume-title":"Neurobiology of the Epilepsies: From Epilepsy: A Comprehensive Textbook","author":"Patel","year":"2022"},{"key":"2026072315343652000_ref7","doi-asserted-by":"publisher","first-page":"01","DOI":"10.31579\/2690-4861\/371","article-title":"Role of ion channelopathy in neurological diseases; role of Gabaergic system connectivity and dysfunction in neurological disorders","volume":"16","author":"Hadjighassem","year":"2024","journal-title":"Int J Clin Case Rep Rev"},{"key":"2026072315343652000_ref8","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/biomedicines9121834","article-title":"Drug delivery challenges in brain disorders across the blood\u2013brain barrier: novel methods and future considerations for improved therapy","volume":"9","author":"Achar","year":"2021","journal-title":"Biomedicines"},{"key":"2026072315343652000_ref9","doi-asserted-by":"publisher","first-page":"108950","DOI":"10.1016\/j.yebeh.2022.108950","article-title":"Unmet needs and perspectives in management of drug resistant focal epilepsy: an Italian study","volume":"137","author":"Mecarelli","year":"2022","journal-title":"Epilepsy Behav"},{"key":"2026072315343652000_ref10","doi-asserted-by":"publisher","first-page":"105788","DOI":"10.1016\/j.jddst.2024.105788","article-title":"Nanocarriers in the treatment of epilepsy: challenges and opportunities","volume":"97","author":"Anjali","year":"2024","journal-title":"J Drug Delivery Sci Technol"},{"key":"2026072315343652000_ref11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/antiox11010157","article-title":"The interconnected mechanisms of oxidative stress and neuroinflammation in epilepsy","volume":"11","author":"Parsons","year":"2022","journal-title":"Antioxidants"},{"key":"2026072315343652000_ref12","doi-asserted-by":"publisher","first-page":"1558263","DOI":"10.3389\/fimmu.2025.1558263","article-title":"Understanding chronic inflammation: couplings between cytokines, ROS, NO, Cai2+, HIF-1\u03b1, Nrf2 and autophagy","volume":"16","author":"Michalak","year":"2025","journal-title":"Front Immunol"},{"key":"2026072315343652000_ref13","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13050732","article-title":"Immunological imbalances associated with epileptic seizures in type 2 diabetes mellitus","volume":"13","author":"Phoswa","year":"2023","journal-title":"Brain Sci"},{"key":"2026072315343652000_ref14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/1535370221989263","article-title":"Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance","volume":"246","author":"Sears","year":"2021","journal-title":"Exp Biol Med"},{"key":"2026072315343652000_ref15","doi-asserted-by":"publisher","first-page":"1077821","DOI":"10.3389\/fphys.2023.1077821","article-title":"Associations between dysbiosis gut microbiota and changes of neurotransmitters and short-chain fatty acids in valproic acid model rats","volume":"14","author":"Zhong","year":"2023","journal-title":"Front Physiol"},{"key":"2026072315343652000_ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115576","article-title":"Evidences for a role of gut microbiota in pathogenesis and management of epilepsy","volume":"22","author":"Amlerova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026072315343652000_ref17","doi-asserted-by":"publisher","first-page":"742449","DOI":"10.3389\/fimmu.2021.742449","article-title":"Microbiota-gut-brain axis and epilepsy: a review on mechanisms and potential therapeutics","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol"},{"key":"2026072315343652000_ref18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2022.07.007","article-title":"Genetic variations in GABA metabolism and epilepsy","volume":"101","author":"Feng","year":"2022","journal-title":"Seizure"},{"key":"2026072315343652000_ref19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00424-010-0816-2","article-title":"Mutations affecting GABAergic signaling in seizures and epilepsy","volume":"460","author":"Galanopoulou","year":"2010","journal-title":"Pfl\u00fcgers Archiv-Eur J Physiol"},{"key":"2026072315343652000_ref20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/biomedicines11030783","article-title":"The role of glutamate receptors in epilepsy","volume":"11","author":"Chen","year":"2023","journal-title":"Biomedicines"},{"key":"2026072315343652000_ref21","doi-asserted-by":"publisher","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","article-title":"Glutamatergic mechanisms associated with seizures and epilepsy","volume":"5","author":"Barker-Haliski","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026072315343652000_ref22","doi-asserted-by":"publisher","volume-title":"Neurosteroids\u2014Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy","author":"Reddy","DOI":"10.1093\/med\/9780199746545.003.0077"},{"key":"2026072315343652000_ref23","doi-asserted-by":"publisher","first-page":"118826","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: an updated review","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci"},{"key":"2026072315343652000_ref24","first-page":"e716","article-title":"Neuron-specific mechanisms for epilepsy self-termination","volume":"2","author":"Wang","year":"2015","journal-title":"Mol Cell Epilepsy"},{"key":"2026072315343652000_ref25","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00415-024-12352-x","article-title":"Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights","volume":"271","author":"Ng","year":"2024","journal-title":"J Neurol"},{"key":"2026072315343652000_ref26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00019052-200304000-00009","article-title":"Channelopathies as a genetic cause of epilepsy","volume":"16","author":"Mulley","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"2026072315343652000_ref27","doi-asserted-by":"publisher","first-page":"e35885","DOI":"10.1371\/journal.pone.0035885","article-title":"The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway","volume":"7","author":"Talos","year":"2012","journal-title":"PLoS ONE"},{"key":"2026072315343652000_ref28","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1242\/jcs.114.11.1971","article-title":"Cyclic AMP signalling","volume":"114","author":"Fimia","year":"2001","journal-title":"J Cell Sci"},{"key":"2026072315343652000_ref29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.npep.2018.09.005","article-title":"Brain-derived neurotrophic factor and epilepsy: a systematic review","volume":"72","author":"Iughetti","year":"2018","journal-title":"Neuropeptides"},{"key":"2026072315343652000_ref30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s42494-023-00137-0","article-title":"Biomolecular mechanisms of epileptic seizures and epilepsy: a review","volume":"5","author":"Sumadewi","year":"2023","journal-title":"Acta Epileptologica"},{"key":"2026072315343652000_ref31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnbeh.2011.00045","article-title":"Cell signaling underlying epileptic behavior","volume":"5","author":"Bozzi","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"2026072315343652000_ref32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"2026072315343652000_ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/795259","article-title":"Oxidative stress and epilepsy: literature review","volume":"2012","author":"Aguiar","year":"2012","journal-title":"Oxidative Med Cell Longev"},{"key":"2026072315343652000_ref34","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/sj.jcbfm.9600149","article-title":"Epilepsy and apoptosis pathways","volume":"25","author":"Henshall","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026072315343652000_ref35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.eplepsyres.2018.07.002","article-title":"Wnt\/\u03b2-catenin signaling as a potential target for novel epilepsy therapies","volume":"146","author":"Hodges","year":"2018","journal-title":"Epilepsy Res"},{"key":"2026072315343652000_ref36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jnr.23770","article-title":"Purinergic signaling in epilepsy","volume":"94","author":"Rassendren","year":"2016","journal-title":"J Neurosci Res"},{"key":"2026072315343652000_ref37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00441-019-03146-z","article-title":"The implications of hippocampal neurogenesis in adolescent rats after status epilepticus: a novel role of notch signaling pathway in regulating epileptogenesis","volume":"380","author":"Yuan","year":"2020","journal-title":"Cell Tissue Res"},{"key":"2026072315343652000_ref38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nbd.2015.08.003","article-title":"Neuronal migration disorders: focus on the cytoskeleton and epilepsy","volume":"92","author":"Stouffer","year":"2016","journal-title":"Neurobiol Dis"},{"key":"2026072315343652000_ref39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1528-1157.1992.tb06227.x","article-title":"Hormones and epilepsy through the lifetime","volume":"33","author":"Morrell","year":"1992","journal-title":"Epilepsia"},{"key":"2026072315343652000_ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42494-022-00103-2","article-title":"Gene variations of glutamate metabolism pathway and epilepsy","volume":"4","author":"Feng","year":"2022","journal-title":"Acta Epileptologica"},{"key":"2026072315343652000_ref41","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1007\/s12035-023-03329-4","article-title":"Selected biomarkers of oxidative stress and energy metabolism disorders in neurological diseases","volume":"60","author":"Korczowska-\u0141\u0105cka","year":"2023","journal-title":"Mol Neurobiol"},{"key":"2026072315343652000_ref42","volume-title":"The Role of Microglial Cells in Modulating Hippocampal Synaptic Plasticity and Serotonergic Antidepressant Efficacy","author":"Golia","year":"2020"},{"key":"2026072315343652000_ref43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jmss.jmss_11_24","article-title":"A review of EEG-based localization of epileptic seizure foci: common points with multimodal fusion of brain data","volume":"14","author":"Tajmirriahi","year":"2024","journal-title":"J Med Signals Sensors"},{"key":"2026072315343652000_ref44","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.dscb.2023.100099","article-title":"Serum levels of oxidative stress biomarkers is changed in pharmacoresistant mesial temporal lobe epilepsy patients with or without psychiatric disorders","volume":"11","author":"Lopes","year":"2023","journal-title":"Brain Disorders"},{"key":"2026072315343652000_ref45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3389\/fneur.2019.00685","article-title":"Advances in the potential biomarkers of epilepsy","volume":"10","author":"Kobylarek","year":"2019","journal-title":"Front Neurol"},{"key":"2026072315343652000_ref46","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1111\/epi.17023","article-title":"Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology","volume":"62","author":"Alvim","year":"2021","journal-title":"Epilepsia"},{"key":"2026072315343652000_ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2015.11.011","article-title":"Circulating CD4 and CD8 T cells expressing pro-inflammatory cytokines in a cohort of mesial temporal lobe epilepsy patients with hippocampal sclerosis","volume":"120","author":"Rosa","year":"2016","journal-title":"Epilepsy Res"},{"key":"2026072315343652000_ref48","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.expneurol.2004.08.008","article-title":"Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood\u2013brain barrier","volume":"190","author":"Wong","year":"2004","journal-title":"Exp Neurol"},{"key":"2026072315343652000_ref49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.lpm.2017.10.020","article-title":"Genetics of human epilepsies: continuing progress","volume":"47","author":"Szepetowski","year":"2018","journal-title":"Presse Med"},{"key":"2026072315343652000_ref50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"Breemen","year":"2007","journal-title":"Lancet Neurol"},{"key":"2026072315343652000_ref51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2011.04.004","article-title":"Mitochondrial dysfunction in epilepsy","volume":"12","author":"Folbergrov\u00e1","year":"2012","journal-title":"Mitochondrion"},{"key":"2026072315343652000_ref52","doi-asserted-by":"publisher","first-page":"114786","DOI":"10.1016\/j.bcp.2021.114786","article-title":"Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development","volume":"193","author":"Green","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"2026072315343652000_ref53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ajmg.c.10018","article-title":"Metabolic disorders and mental retardation","volume":"117C","author":"Kahler","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2026072315343652000_ref54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/exnr.1994.1077","article-title":"Regional and temporal pattern of expression of nerve growth factor and basic fibroblast growth factor mRNA in rat brain following electroconvulsive shock","volume":"127","author":"Follesa","year":"1994","journal-title":"Exp Neurol"},{"key":"2026072315343652000_ref55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2020.09.015","article-title":"Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: from pathogenesis to treatment target","volume":"82","author":"Mukhtar","year":"2020","journal-title":"Seizure"},{"key":"2026072315343652000_ref56","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure medications for adults with epilepsy: a review","volume":"327","author":"Kanner","year":"2022","journal-title":"JAMA"},{"key":"2026072315343652000_ref57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42494-023-00127-2","article-title":"Therapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy","volume":"5","author":"Agbo","year":"2023","journal-title":"Acta Epileptologica"},{"key":"2026072315343652000_ref58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.eplepsyres.2017.02.003","article-title":"Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy","volume":"131","author":"Radu","year":"2017","journal-title":"Epilepsy Res"},{"key":"2026072315343652000_ref59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/metabo13010134","article-title":"Therapeutic and toxic effects of valproic acid metabolites","volume":"13","author":"Shnayder","year":"2023","journal-title":"Metabolites"},{"key":"2026072315343652000_ref60","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/jpm13040623","article-title":"State of the art and challenges in epilepsy\u2014a narrative review","volume":"13","author":"Manole","year":"2023","journal-title":"J Pers Med"},{"key":"2026072315343652000_ref61","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/1389557523666221208104530","article-title":"US-FDA approved drugs in 2020 and 2021: a review","volume":"23","author":"Passi","year":"2023","journal-title":"Mini Rev Med Chem"},{"key":"2026072315343652000_ref62","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1007\/s10072-024-07513-9","article-title":"The role of neuromodulation in the management of drug-resistant epilepsy","volume":"45","author":"Salama","year":"2024","journal-title":"Neurol Sci"},{"key":"2026072315343652000_ref63","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1517\/14656566.2016.1168399","article-title":"Carbamazepine-related antiepileptic drugs for the treatment of epilepsy-a comparative review","volume":"17","author":"Gierbolini","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"2026072315343652000_ref64","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2165\/00023210-200721090-00005","article-title":"Extended-release formulations for the treatment of epilepsy","volume":"21","author":"Bialer","year":"2007","journal-title":"CNS Drugs"},{"key":"2026072315343652000_ref65","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/ajhp\/50.12_Suppl_5.S17","article-title":"Biopharmaceutical factors in seizure control and drug toxicity","volume":"50","author":"Meyer","year":"1993","journal-title":"Am J Hosp Pharm"},{"key":"2026072315343652000_ref66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0920-1211(00)00149-2","article-title":"Tiagabine in the treatment of epilepsy\u2014a clinical review with a guide for the prescribing physician","volume":"41","author":"Schmidt","year":"2000","journal-title":"Epilepsy Res"},{"key":"2026072315343652000_ref67","first-page":"266","article-title":"Formulation of immediate release lamotrigine tablets and bioequivalence study","volume":"5","author":"Bary","year":"2013","journal-title":"J Chem Pharm Res"},{"key":"2026072315343652000_ref68","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/NDT.S4844","article-title":"Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures","volume":"5","author":"Ulloa","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2026072315343652000_ref69","first-page":"683","article-title":"Perampanel (Fycompa): a review of clinical efficacy and safety in epilepsy","volume":"41","author":"Greenwood","year":"2016","journal-title":"Pharm Ther"},{"key":"2026072315343652000_ref70","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s40268-013-0016-6","article-title":"Bioequivalence of eslicarbazepine acetate from two different sources of its active product ingredient in healthy subjects","volume":"13","author":"Falc\u00e3o","year":"2013","journal-title":"Drugs R D"},{"key":"2026072315343652000_ref71","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.yebeh.2015.05.012","article-title":"A pharmacological basis of herbal medicines for epilepsy","volume":"52","author":"Sucher","year":"2015","journal-title":"Epilepsy Behav"},{"key":"2026072315343652000_ref72","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/antiox13111364","article-title":"Role of plant phytochemicals: resveratrol, curcumin, luteolin and quercetin in demyelination, neurodegeneration, and epilepsy","volume":"13","author":"Grabarczyk","year":"2024","journal-title":"Antioxidants"},{"key":"2026072315343652000_ref73","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-981-99-7269-2_10","volume-title":"Neuroprotective Effects of Phytochemicals in Brain Ageing","author":"Gopathy","year":"2024"},{"key":"2026072315343652000_ref74","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1389200222666210203182716","article-title":"Withania somnifera in neurological disorders: ethnopharmacological evidence, mechanism of action and its progress in delivery systems","volume":"22","author":"Syed","year":"2021","journal-title":"Curr Drug Metab"},{"key":"2026072315343652000_ref76","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.omtm.2018.03.001","article-title":"Seizure-suppressant and neuroprotective effects of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy","volume":"9","author":"Falcicchia","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2026072315343652000_ref77","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainresbull.2017.07.006","article-title":"Intranasal nerve growth factor attenuating the seizure onset via p75R\/caspase pathway in the experimental epilepsy","volume":"134","author":"Feng","year":"2017","journal-title":"Brain Res Bull"},{"key":"2026072315343652000_ref78","doi-asserted-by":"publisher","first-page":"147881","DOI":"10.1016\/j.brainres.2022.147881","article-title":"Anti-inflammatory and neuroprotective effects of insulin-like growth factor-1 overexpression in pentylenetetrazole (PTZ)-induced mouse model of chronic epilepsy","volume":"1785","author":"Wu","year":"2022","journal-title":"Brain Res"},{"key":"2026072315343652000_ref79","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/IJN.S15881","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int J Nanomed"},{"key":"2026072315343652000_ref80","doi-asserted-by":"publisher","first-page":"908386","DOI":"10.3389\/fchem.2022.908386","article-title":"Novel phenobarbital-loaded nanostructured lipid carriers for epilepsy treatment: from QbD to in vivo evaluation","volume":"10","author":"Scioli-Montoto","year":"2022","journal-title":"Front Chem"},{"key":"2026072315343652000_ref81","doi-asserted-by":"publisher","first-page":"119033","DOI":"10.1016\/j.ijpharm.2020.119033","article-title":"Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity","volume":"577","author":"Khan","year":"2020","journal-title":"Int J Pharm"},{"key":"2026072315343652000_ref82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2012.05.058","article-title":"Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats","volume":"1469","author":"Ma","year":"2012","journal-title":"Brain Res"},{"key":"2026072315343652000_ref83","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.seizure.2007.05.016","article-title":"Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice","volume":"16","author":"Dhir","year":"2007","journal-title":"Seizure"},{"key":"2026072315343652000_ref84","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0006-8993(88)90556-2","article-title":"Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats","volume":"462","author":"Ikonomidou-Turski","year":"1988","journal-title":"Brain Res"},{"key":"2026072315343652000_ref85","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nbd.2006.02.016","article-title":"Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"23","author":"Jung","year":"2006","journal-title":"Neurobiol Dis"},{"key":"2026072315343652000_ref86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0306-4522(96)00420-4","article-title":"Lipofectin-facilitated transfer of cholecystokinin gene corrects behavioral abnormalities of rats with audiogenic seizures","volume":"77","author":"Zhang","year":"1997","journal-title":"Neuroscience"},{"key":"2026072315343652000_ref87","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ymthe.2005.12.013","article-title":"Intranasal administration of the growth-compromised HSV-2 vector \u0394RR prevents kainate-induced seizures and neuronal loss in rats and mice","volume":"13","author":"Laing","year":"2006","journal-title":"Mol Ther"},{"key":"2026072315343652000_ref88","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/exnr.2002.7914","article-title":"Genetically engineered GABA-producing cells demonstrate anticonvulsant effects and long-term transgene expression when transplanted into the central piriform cortex of rats","volume":"176","author":"Gernert","year":"2002","journal-title":"Exp Neurol"},{"key":"2026072315343652000_ref89","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1460-9568.2003.02926.x","article-title":"Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development","volume":"18","author":"Lin","year":"2003","journal-title":"Eur J Neurosci"},{"key":"2026072315343652000_ref90","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.expneurol.2006.02.132","article-title":"Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus","volume":"200","author":"Yoo","year":"2006","journal-title":"Exp Neurol"},{"key":"2026072315343652000_ref91","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1073\/pnas.210350097","article-title":"Sparing of neuronal function postseizure with gene therapy","volume":"97","author":"McLaughlin","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"2026072315343652000_ref92","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jep.2013.03.045","article-title":"Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals","volume":"147","author":"Lin","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"2026072315343652000_ref93","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3109\/13880209.2013.803128","article-title":"Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy","volume":"51","author":"Kiasalari","year":"2013","journal-title":"Pharm Biol"},{"key":"2026072315343652000_ref94","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/13880209.2016.1260597","article-title":"Assessment of luteolin isolated from Eclipta alba leaves in animal models of epilepsy","volume":"55","author":"Tambe","year":"2017","journal-title":"Pharm Biol"},{"key":"2026072315343652000_ref95","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000486768","article-title":"Ginsenoside Rb1 protects the brain from damage induced by epileptic seizure via Nrf2\/ARE signaling","volume":"45","author":"Shi","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2026072315343652000_ref96","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1021\/acschemneuro.9b00575","article-title":"Tetramethylpyrazine reduces epileptogenesis progression in electrical kindling models by modulating hippocampal excitatory neurotransmission","volume":"10","author":"Jin","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"2026072315343652000_ref97","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00210-016-1220-z","article-title":"Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice","volume":"389","author":"Tambe","year":"2016","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"2026072315343652000_ref98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1208\/s12249-024-02870-2","article-title":"Formulation, optimization and In-vivo characterization of thermosensitive In-situ nasal gel loaded with bacoside a for treatment of epilepsy","volume":"25","author":"Mankar","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"2026072315343652000_ref99","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.962223","article-title":"Up-and-coming anti-epileptic effect of aloesone in Aloe vera: evidenced by integrating network pharmacological analysis, in vitro, and in vivo models","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026072315343652000_ref100","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1016\/j.xphs.2022.09.012","article-title":"Lipid nano-carriers loaded with Cannabis sativa extract for epilepsy treatment\u2014in vitro characterization and in vivo efficacy studies","volume":"111","author":"Mihailova","year":"2022","journal-title":"J Pharm Sci"},{"key":"2026072315343652000_ref101","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/ph16091223","article-title":"Ameliorative effect of ethanolic extract of Moringa oleifera leaves in combination with curcumin against PTZ-induced kindled epilepsy in rats","volume":"16","author":"Alam","year":"2023","journal-title":"In Vivo In Silico Pharm"},{"key":"2026072315343652000_ref75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1528-1167.2008.01743.x","article-title":"Gene therapy in epilepsy","volume":"50","author":"Riban","year":"2009","journal-title":"Epilepsia"},{"key":"2026072315343652000_ref102","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/molecules30040848","article-title":"The role of brain-derived neurotrophic factor as an essential mediator in neuronal functions and the therapeutic potential of its mimetics for neuroprotection in neurologic and psychiatric disorders","volume":"30","author":"Numakawa","year":"2025","journal-title":"Molecules"},{"key":"2026072315343652000_ref103","doi-asserted-by":"publisher","first-page":"1934578X251367650","DOI":"10.1177\/1934578X251367650","article-title":"Metabolomics-driven standardization of herbal medicine: advances, applications, and sustainability considerations","volume":"20","author":"Alum","year":"2025","journal-title":"Nat Prod Commun"},{"key":"2026072315343652000_ref104","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s43094-021-00256-w","article-title":"Current perspectives in herbal and conventional drug interactions based on clinical manifestations","volume":"7","author":"Surana","year":"2021","journal-title":"Future J Pharm Sci"},{"key":"2026072315343652000_ref105","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/joim.70059","article-title":"Gene therapy for epilepsy: an emerging, promising approach for a serious neurological disorder","volume":"299","author":"Ledri","year":"2026","journal-title":"J Intern Med"},{"key":"2026072315343652000_ref106","doi-asserted-by":"publisher","first-page":"107759","DOI":"10.1016\/j.jddst.2025.107759","article-title":"Frontiers and challenges in brain drug delivery: emerging nanotechnology approaches to overcome the blood-brain barrier for neurodegenerative disease treatment","volume":"115","author":"Bahuguna","year":"2026","journal-title":"J Drug Deliv Sci Technol"},{"key":"2026072315343652000_ref107","doi-asserted-by":"publisher","first-page":"e1153568","DOI":"10.1080\/21688370.2016.1153568","article-title":"Nanoparticle transport across the blood brain barrier","volume":"4","author":"Grabrucker","year":"2016","journal-title":"Tissue Barriers"},{"key":"2026072315343652000_ref108","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.2174\/138920112803341851","article-title":"Adsorptive-mediated brain delivery systems","volume":"13","author":"Lu","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"2026072315343652000_ref109","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1021\/nn300240p","article-title":"Receptor-mediated delivery of magnetic nanoparticles across the blood\u2013brain barrier","volume":"6","author":"Qiao","year":"2012","journal-title":"ACS Nano"},{"key":"2026072315343652000_ref110","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/B978-0-12-814001-7.00006-8","volume-title":"Brain Targeted Drug Delivery System","author":""},{"key":"2026072315343652000_ref111","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.peptides.2014.04.015","article-title":"Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules","volume":"57","author":"Farkhani","year":"2014","journal-title":"Peptides"},{"key":"2026072315343652000_ref112","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/1871527320666210706104240","article-title":"Lipid nanocarriers for neurotherapeutics: introduction, challenges, blood-brain barrier, and promises of delivery approaches","volume":"21","author":"Aslam","year":"2022","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2026072315343652000_ref113","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"key":"2026072315343652000_ref114","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.2147\/IJN.S62260","article-title":"Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood\u2013brain barrier","volume":"9","author":"Sun","year":"2014","journal-title":"Int J Nanomed"},{"key":"2026072315343652000_ref115","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/ph16101424","article-title":"Liposome-derived nanosystems for the treatment of behavioral and neurodegenerative diseases: the promise of niosomes, transfersomes, and ethosomes for increased brain drug bioavailability","volume":"16","author":"Pires","year":"2023","journal-title":"Pharmaceuticals"},{"key":"2026072315343652000_ref116","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s12668-023-01215-w","article-title":"Insights into the pivotal role of calcium channel blockers and its nanoformulations in the management of hypertension","volume":"13","author":"Grewal","year":"2023","journal-title":"Bio Nano Sci"},{"key":"2026072315343652000_ref117","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/9781119811794.ch17","article-title":"Nanotherapeutics of phytoantioxidants for inflammatory disorders","author":"Palai","year":"2022","journal-title":"Phytoantioxidants Nanotherapeutics"},{"key":"2026072315343652000_ref118","article-title":"Vesicular drug delivery systems: a novel approach for drug targeting","volume":"1","author":"","year":"2013","journal-title":"Brain"},{"key":"2026072315343652000_ref119","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-91611-0.00014-1","volume-title":"Smart Polymer Nanocomposites: Design, Synthesis, Functionalization, Properties, and Applications","author":"Rashid","year":"2022"},{"key":"2026072315343652000_ref120","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.3390\/ma16247550","article-title":"Organic and biogenic nanocarriers as bio-friendly systems for bioactive compounds\u2019 delivery: state-of-the art and challenges","volume":"16","author":"Petrovic","year":"2023","journal-title":"Materials"},{"key":"2026072315343652000_ref121","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/08982104.2020.1730401","article-title":"Vesicle formation mechanisms: an overview","volume":"31","author":"Has","year":"2021","journal-title":"J Liposome Res"},{"key":"2026072315343652000_ref122","first-page":"14","article-title":"Novel drug delivery systems and its future prospects","volume":"1","author":"Rayate","year":"2023","journal-title":"World J Appl Pharm"},{"key":"2026072315343652000_ref123","doi-asserted-by":"publisher","first-page":"47","DOI":"10.22270\/jddt.v0i0.843","article-title":"Liposomes: an overview","volume":"4","author":"Vishvakrama","year":"2014","journal-title":"J Drug Deliv Ther"},{"key":"2026072315343652000_ref124","doi-asserted-by":"publisher","first-page":"105636","DOI":"10.1016\/j.phrs.2021.105636","article-title":"New application of an old drug proparacaine in treating epilepsy via liposomal hydrogel formulation","volume":"169","author":"Taleb","year":"2021","journal-title":"Pharmacol Res"},{"key":"2026072315343652000_ref125","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1472-8206.2011.01002.x","article-title":"Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice","volume":"27","author":"Agarwal","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"2026072315343652000_ref126","first-page":"247","article-title":"Evaluation of liposomal gossypin in animal models of epilepsy","volume":"8","author":"Nagpal","year":"2016","journal-title":"Int J Pharm Pharm Sci"},{"key":"2026072315343652000_ref127","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2017.05.026","article-title":"Anticonvulsant activity of resveratrol-loaded liposomes in vivo","volume":"357","author":"Ethemoglu","year":"2017","journal-title":"Neuroscience"},{"key":"2026072315343652000_ref128","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12035-025-05398-z","article-title":"Intranasal liposomal trimetazidine nanocarriers modulate neuroinflammation and neurotransmission via the HMGB1\/TLR4\/NF-\u03baB pathway in an experimental epilepsy model","volume":"63","author":"Majid","year":"2025","journal-title":"Mol Neurobiol"},{"key":"2026072315343652000_ref129","first-page":"1","article-title":"Novel drug delivery system for the vesicular delivery of drug by the niosomes","volume":"1","author":"Keservani","year":"2011","journal-title":"Int J Res Control Release"},{"key":"2026072315343652000_ref130","doi-asserted-by":"publisher","first-page":"264","DOI":"10.22159\/ijap.2019v11i4.33474","article-title":"Carbamazepine loaded vesicular structures for enhanced brain targeting via intranasal route: Optimization, in vitro evaluation, and in vivo study","author":"Yassin","year":"2019","journal-title":"Int J Res Appl Pharm"},{"key":"2026072315343652000_ref131","first-page":"100206","article-title":"Novel nasal niosomes loaded with lacosamide and coated with chitosan: a possible pathway to target the brain to control partial-onset seizures","volume":"6","author":"Tulbah","year":"2023","journal-title":"Int J Pharm X"},{"key":"2026072315343652000_ref132","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.xphs.2022.02.012","article-title":"Intranasal niosomal in situ gel as a novel strategy for improving citicoline efficacy and brain delivery in treatment of epilepsy: In vitro and ex vivo characterization and In vivo pharmacodynamics investigation","volume":"111","author":"Bekhet","year":"2022","journal-title":"J Pharm Sci"},{"key":"2026072315343652000_ref133","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0973-8398.102930","article-title":"Emulsomes: An emerging vesicular drug delivery system","volume":"6","author":"Gill","year":"2012","journal-title":"Asian J Pharm"},{"key":"2026072315343652000_ref134","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/pharmaceutics10040217","article-title":"A tailored thermosensitive PLGA-PEG-PLGA\/emulsomes composite for enhanced oxcarbazepine brain delivery via the nasal route","volume":"10","author":"El-Zaafarany","year":"2018","journal-title":"Pharmaceutics"},{"key":"2026072315343652000_ref135","first-page":"435","article-title":"Transferosomes\u2014a review","volume":"5","author":"","year":"2016","journal-title":"World J Pharm Pharm Sci"},{"key":"2026072315343652000_ref136","article-title":"Nose to brain delivery of naringin loaded transniosomes for epilepsy: formulation, characterisation, blood-brain distribution and invivo pharmacodynamic evaluation","volume":"34","author":"Gupta","journal-title":"J Liposome Res"},{"key":"2026072315343652000_ref137","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3109\/08982104.2012.700460","article-title":"Brain delivery of olanzapine by intranasal administration of transfersomal vesicles","volume":"22","author":"Salama","year":"2012","journal-title":"J Liposome Res"},{"key":"2026072315343652000_ref138","doi-asserted-by":"publisher","first-page":"000107","DOI":"10.23880\/OAJPR-16000107","article-title":"Transferosomes for trans-nasal brain delivery of clonazepam: preparation, optimization, ex-vivo cytotoxicity and pharmacodynamic study","volume":"1","author":"Sa","year":"2017","journal-title":"Pharm Res"},{"key":"2026072315343652000_ref139","doi-asserted-by":"publisher","first-page":"106827","DOI":"10.1016\/j.jddst.2025.106827","article-title":"Transdermal transfersomal hydrogel: a breakthrough in carbamazepine delivery for effective epilepsy management","volume":"107","author":"Hussain","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"key":"2026072315343652000_ref140","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/chemengineering9030056","article-title":"Liposome-based drug delivery systems: from laboratory research to industrial production\u2014instruments and challenges","volume":"9","author":"Basak","year":"2025","journal-title":"Chem Eng"},{"key":"2026072315343652000_ref141","doi-asserted-by":"publisher","first-page":"15352","DOI":"10.3390\/ijms242015352","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026072315343652000_ref142","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1080\/17425247.2016.1218462","article-title":"From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)","volume":"14","author":"Rehman","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"2026072315343652000_ref143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24262\/jmd.2.2.17015","article-title":"Development of NDDS of carbamazepine in epilepsy for medical discovery of formulation significance","volume":"2","author":"Kumar","year":"2017","journal-title":"J Med Discov"},{"key":"2026072315343652000_ref144","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.2147\/DDDT.S263898","article-title":"Development, characterization, and in-vivo pharmacokinetic study of lamotrigine solid self-nanoemulsifying drug delivery system","volume":"14","author":"Abdelmonem","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"2026072315343652000_ref145","volume-title":"Evaluating the Bioavailability of Carbamazepine Using a Novel SNEDDS Formulation","author":"","year":"2014"},{"key":"2026072315343652000_ref146","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/polym14122510","article-title":"A review of polymeric micelles and their applications","volume":"14","author":"Perumal","year":"2022","journal-title":"Polymers"},{"key":"2026072315343652000_ref147","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1080\/10717544.2016.1223216","article-title":"Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies","volume":"23","author":"Nour","year":"2016","journal-title":"Drug Deliv"},{"key":"2026072315343652000_ref148","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.2147\/IJN.S145488","article-title":"mPEG-PLA\/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus","volume":"12","author":"Yu","year":"2017","journal-title":"Int J Nanomed"},{"key":"2026072315343652000_ref149","doi-asserted-by":"publisher","first-page":"105978","DOI":"10.1016\/j.ejps.2021.105978","article-title":"Micellar buccal film for safe and effective control of seizures: preparation, in vitro characterization, ex vivo permeation studies and in vivo assessment","volume":"166","author":"Salama","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"2026072315343652000_ref150","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.2147\/IJN.S62263","article-title":"Enhanced brain delivery of lamotrigine with Pluronic\u00ae P123-based nanocarrier","author":"Liu","year":"2014","journal-title":"Int J Nanomed"},{"key":"2026072315343652000_ref151","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.apsb.2022.09.019","article-title":"ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"2026072315343652000_ref152","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/0975-8453.59509","article-title":"Nanoemulsion: a pharmaceutical review","volume":"1","author":"Shah","year":"2010","journal-title":"Syst Rev Pharm"},{"key":"2026072315343652000_ref153","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijpharm.2019.04.076","article-title":"Design and development of letrozole nanoemulsion: a comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice","volume":"565","author":"Iqbal","year":"2019","journal-title":"Int J Pharm"},{"key":"2026072315343652000_ref154","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/21691401.2018.1489826","article-title":"RETRACTED ARTICLE: impact of ultrasonication techniques on the preparation of novel amiloride-nanoemulsion used for intranasal delivery in the treatment of epilepsy","volume":"46","author":"Ahmad","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2026072315343652000_ref155","doi-asserted-by":"publisher","first-page":"119486","DOI":"10.1016\/j.ijpharm.2020.119486","article-title":"Intranasal delivery of topiramate nanoemulsion: pharmacodynamic, pharmacokinetic and brain uptake studies","volume":"585","author":"Patel","year":"2020","journal-title":"Int J Pharm"},{"key":"2026072315343652000_ref156","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s10517-014-2657-z","article-title":"Experimental investigation of pharmacodynamics and pharmacokinetics of carbamazepine nanoemulsion","volume":"157","author":"Prokhorov","year":"2014","journal-title":"Bull Exp Biol Med"},{"key":"2026072315343652000_ref157","volume-title":"Fundamentals of Bionanomaterials","author":"","year":"2022"},{"key":"2026072315343652000_ref158","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1021\/acschemneuro.0c00242","article-title":"Solid lipid nanoparticles enhanced the neuroprotective role of curcumin against epilepsy through activation of Bcl-2 family and P38 MAPK pathways","volume":"11","author":"Huang","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"2026072315343652000_ref159","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.3390\/molecules24213971","article-title":"Preparation and evaluation of carbamazepine solid lipid nanoparticle for alleviating seizure activity in pentylenetetrazole-kindled mice","volume":"24","author":"Qushawy","year":"2019","journal-title":"Molecules"},{"key":"2026072315343652000_ref160","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/jps.24044","article-title":"Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram","volume":"103","author":"Leyva-G\u00f3mez","year":"2014","journal-title":"J Pharm Sci"},{"key":"2026072315343652000_ref161","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfb.2018.03.052","article-title":"Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro\/in vivo evaluation","volume":"167","author":"Montoto","year":"2018","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"2026072315343652000_ref162","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1476-511X-11-72","article-title":"Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine","volume":"11","author":"Nair","year":"2012","journal-title":"Lipids Health Dis"},{"key":"2026072315343652000_ref163","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier","volume":"51","author":"Salvi","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"2026072315343652000_ref164","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1517\/17425247.2014.945416","article-title":"Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy","volume":"12","author":"Alam","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"2026072315343652000_ref165","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1049\/iet-nbt.2019.0156","article-title":"In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus","volume":"14","author":"Taymouri","year":"2020","journal-title":"IET Nanobiotechnol"},{"key":"2026072315343652000_ref166","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.3390\/polym15234563","article-title":"Recent advances in micro-and nano-drug delivery systems based on natural and synthetic biomaterials","volume":"15","author":"Harun-Or-Rashid","year":"2023","journal-title":"Polymers"},{"key":"2026072315343652000_ref167","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/pharmaceutics15030976","article-title":"Polymeric micellar systems\u2014a special emphasis on \u201csmart\u201d drug delivery","volume":"15","author":"Negut","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026072315343652000_ref168","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/138955713804484721","article-title":"Functional PLGA NPs for oral drug delivery: recent strategies and developments","volume":"13","author":"Martin-Banderas","year":"2013","journal-title":"Mini Rev Med Chem"},{"key":"2026072315343652000_ref169","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejpb.2018.11.002","article-title":"Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents","volume":"133","author":"Musumeci","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"2026072315343652000_ref170","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/21691401.2021.1939709","article-title":"Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study","volume":"49","author":"Shah","year":"2021","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2026072315343652000_ref171","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/03639045.2020.1769127","article-title":"Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method: in vitro and in vivo studies","volume":"46","author":"Kandilli","year":"2020","journal-title":"Drug Dev Ind Pharm"},{"key":"2026072315343652000_ref172","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.nano.2018.01.019","article-title":"Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: a new anti-seizure strategy for temporal lobe epilepsy","volume":"14","author":"Cano","year":"2018","journal-title":"Nanomedicine"},{"key":"2026072315343652000_ref173","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/jctb.464","article-title":"Dendrimers: a review of their appeal and applications","volume":"76","author":"Dykes","year":"2001","journal-title":"J Chem Technol Biotechnol"},{"key":"2026072315343652000_ref174","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.nano.2011.02.005","article-title":"Effect of a nanostructured dendrimer-naloxonazine complex on endogenous opioid peptides \u03bc1 receptor-mediated post-ictal antinociception","volume":"7","author":"Felippotti","year":"2011","journal-title":"Nanomedicine"},{"key":"2026072315343652000_ref175","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/ten.tea.2021.0218","article-title":"Calcium phosphate and silicate-based nanoparticles: history and emerging trends","volume":"28","author":"Van Rijt","year":"2022","journal-title":"Tissue Eng A"},{"key":"2026072315343652000_ref196","first-page":"72","article-title":"Preparation and characterization of ligand anchored polymeric nanoparticles for the treatment of epilepsy","volume":"13","author":"Parashar","year":"2021","journal-title":"Pharmaspire"},{"key":"2026072315343652000_ref197","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/02652048.2016.1234515","article-title":"In vitro\/in vivo evaluation of gamma-aminobutyric acid-loaded N, N-dimethylacrylamide-based pegylated polymeric nanoparticles for brain delivery to treat epilepsy","volume":"33","author":"Yurtda\u015f K\u0131r\u0131ml\u0131o\u011flu","year":"2016","journal-title":"J Microencapsul"},{"key":"2026072315343652000_ref198","doi-asserted-by":"publisher","first-page":"104988","DOI":"10.1016\/j.ejps.2019.104988","article-title":"Piperine-loaded nanoparticles with enhanced dissolution and oral bioavailability for epilepsy control","volume":"137","author":"Ren","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"2026072315343652000_ref199","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/01932690701718735","article-title":"Development and characterization of liposome-based formulation of amiloride hydrochloride","volume":"29","author":"Alam","year":"2008","journal-title":"J Dispers Sci Technol"},{"key":"2026072315343652000_ref200","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/pharmaceutics15020641","article-title":"Spanlastics as a potential approach for enhancing the nose-to-brain delivery of piperine: In vitro prospect and in vivo therapeutic efficacy for the management of epilepsy","volume":"15","author":"Gupta","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026072315343652000_ref201","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/ph13110356","article-title":"Liquid crystalline nanoparticles for nasal delivery of rosuvastatin: implications on therapeutic efficacy in management of epilepsy","volume":"13","author":"Ahmed","year":"2020","journal-title":"Pharmaceuticals"},{"key":"2026072315343652000_ref202","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/10837450.2023.2216755","article-title":"Cubosome-based thermosensitive in situ gelling system for intranasal administration of lamotrigine with enhanced antiepileptic efficacy","volume":"28","author":"Mohsen","year":"2023","journal-title":"Pharm Dev Technol"},{"key":"2026072315343652000_ref203","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/17425247.2023.2153831","article-title":"Design and evaluation of chrysin-loaded nanoemulsion against lithium\/pilocarpine-induced status epilepticus in rats; emphasis on formulation, neuronal excitotoxicity, oxidative stress, microglia polarization, and AMPK\/SIRT-1\/PGC-1\u03b1 pathway","volume":"20","author":"George","year":"2023","journal-title":"Expert Opin Drug Deliv"},{"key":"2026072315343652000_ref204","doi-asserted-by":"publisher","first-page":"12644","DOI":"10.1002\/ange.201403846","article-title":"Angiopep-conjugated electro-responsive hydrogel nanoparticles: therapeutic potential for epilepsy","volume":"126","author":"Ying","year":"2014","journal-title":"Angew Chem"},{"key":"2026072315343652000_ref205","doi-asserted-by":"publisher","first-page":"105005","DOI":"10.1088\/1361-6439\/ac2127","article-title":"Implanted microelectrode arrays for evaluating inhibited seizure modulated by light-responsive hydrogel","volume":"31","author":"Xie","year":"2021","journal-title":"J Micromech Microeng"},{"key":"2026072315343652000_ref206","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jconrel.2012.05.038","article-title":"Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide","volume":"161","author":"Hsiao","year":"2012","journal-title":"J Control Release"},{"key":"2026072315343652000_ref176","first-page":"2502","article-title":"A review on nanoparticles: their synthesis and types","volume":"2277","author":"Hasan","year":"2015","journal-title":"Res J Recent Sci"},{"key":"2026072315343652000_ref177","first-page":"34","article-title":"Short review on application of gold nanoparticles","volume":"7","author":"Tomar","year":"2013","journal-title":"Glob J Pharmacol"},{"key":"2026072315343652000_ref178","doi-asserted-by":"publisher","first-page":"118081","DOI":"10.1016\/j.lfs.2020.118081","article-title":"Targeted delivery of lacosamide-conjugated gold nanoparticles into the brain in temporal lobe epilepsy in rats","volume":"257","author":"Yilmaz","year":"2020","journal-title":"Life Sci"},{"key":"2026072315343652000_ref179","doi-asserted-by":"publisher","first-page":"e91360","DOI":"10.1371\/journal.pone.0091360","article-title":"Intracellular gold nanoparticles increase neuronal excitability and aggravate seizure activity in the mouse brain","volume":"9","author":"Jung","year":"2014","journal-title":"PLoS ONE"},{"key":"2026072315343652000_ref207","volume-title":"Neuropeptide-Expressing Vectors and Methods for the Treatment of Epilepsy","author":"Heilbronn","year":"2026"},{"key":"2026072315343652000_ref208","volume-title":"Gene and Cell Therapy Using Cell Fusion Technology","author":"Sung","year":"2023"},{"key":"2026072315343652000_ref209","volume-title":"Methods of Treating Central Nervous System Disorders Via Administration of Nanoparticles of an mTOR Inhibitor and an Albumin","author":"Desai, Neil","year":"2025"},{"key":"2026072315343652000_ref210","volume-title":"Nanoparticles for Use for Treating a Neuronal Disorder","author":"Meyre","year":"2024"},{"key":"2026072315343652000_ref211","volume-title":"Pharmaceutical Formulation","author":"Boyer","year":"2023"},{"key":"2026072315343652000_ref212"},{"key":"2026072315343652000_ref213"},{"key":"2026072315343652000_ref214"},{"key":"2026072315343652000_ref215"},{"key":"2026072315343652000_ref216"},{"key":"2026072315343652000_ref217"},{"key":"2026072315343652000_ref218"},{"key":"2026072315343652000_ref219"},{"key":"2026072315343652000_ref220"},{"key":"2026072315343652000_ref221"},{"key":"2026072315343652000_ref180","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4103\/0975-7406.72127","article-title":"Introduction to metallic nanoparticles","volume":"2","author":"Mody","year":"2010","journal-title":"J Pharm Bioallied Sci"},{"key":"2026072315343652000_ref181","doi-asserted-by":"publisher","DOI":"10.15419\/bmrat.v9i9.766","volume":"9","author":"","journal-title":"Biomed Res Ther"},{"key":"2026072315343652000_ref182","volume":"11","author":"","journal-title":"Materials Express"},{"key":"2026072315343652000_ref183","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5101\/nbe.v14i4.p295-307","article-title":"Green synthesis, characterization and antiepileptic activity of herbal nanoparticles of Mimusops elengi in mice","volume":"14","author":"Rajangam","year":"2022","journal-title":"Nano Biomed Eng"},{"key":"2026072315343652000_ref222"},{"key":"2026072315343652000_ref223"},{"key":"2026072315343652000_ref224"},{"key":"2026072315343652000_ref225"},{"key":"2026072315343652000_ref226"},{"key":"2026072315343652000_ref227"},{"key":"2026072315343652000_ref228"},{"key":"2026072315343652000_ref229"},{"key":"2026072315343652000_ref230"},{"key":"2026072315343652000_ref231"},{"key":"2026072315343652000_ref232"},{"key":"2026072315343652000_ref233"},{"key":"2026072315343652000_ref234"},{"key":"2026072315343652000_ref235"},{"key":"2026072315343652000_ref236"},{"key":"2026072315343652000_ref237"},{"key":"2026072315343652000_ref184","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.biopha.2018.12.146","article-title":"Therapeutic applications of selenium nanoparticles","volume":"111","author":"Khurana","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2026072315343652000_ref185","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.2147\/IJN.S259134","article-title":"Selenium nanoparticles pre-treatment reverse behavioral, oxidative damage, neuronal loss and neurochemical alterations in pentylenetetrazole-induced epileptic seizures in mice","volume":"15","author":"Yuan","year":"2020","journal-title":"Int J Nanomed"},{"key":"2026072315343652000_ref186","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/biology11030354","article-title":"Selenium nanoparticles with prodigiosin rescue hippocampal damage associated with epileptic seizures induced by pentylenetetrazole in rats","volume":"11","author":"Al Omairi","year":"2022","journal-title":"Biology"},{"key":"2026072315343652000_ref187","doi-asserted-by":"publisher","first-page":"20230010","DOI":"10.1515\/gps-2023-0010","article-title":"Rutin-loaded selenium nanoparticles modulated the redox status, inflammatory, and apoptotic pathways associated with pentylenetetrazole-induced epilepsy in mice","volume":"12","author":"Mohamed","year":"2023","journal-title":"Green Process Synth"},{"key":"2026072315343652000_ref188","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40820-015-0040-x","article-title":"Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism","volume":"7","author":"Sirelkhatim","year":"2015","journal-title":"Nano-Micro Lett"},{"key":"2026072315343652000_ref189","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.3390\/molecules27154753","article-title":"Magnesium and zinc oxide nanoparticles from Datura alba improve cognitive impairment and blood brain barrier leakage","volume":"27","author":"Ullah","year":"2022","journal-title":"Molecules"},{"key":"2026072315343652000_ref190","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40360-023-00647-0","article-title":"Zinc oxide calcium silicate composite attenuates acute tramadol toxicity in mice","volume":"24","author":"ElShebiney","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"key":"2026072315343652000_ref191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.btre.2017.11.008","article-title":"Synthesis and biomedical applications of cerium oxide nanoparticles\u2014a review","volume":"17","author":"Rajeshkumar","year":"2018","journal-title":"Biotechnol Rep"},{"key":"2026072315343652000_ref192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11094-023-02933-x","article-title":"Preparation of cinnamon-coated cerium oxide nanoparticles and evaluation of their anticonvulsant effect in rats","volume":"57","author":"Mojarrad","year":"2023","journal-title":"Pharm Chem J"},{"key":"2026072315343652000_ref193","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12011-014-0197-z","article-title":"Cerium and yttrium oxide nanoparticles against lead-induced oxidative stress and apoptosis in rat hippocampus","volume":"164","author":"Hosseini","year":"2015","journal-title":"Biol Trace Elem Res"},{"key":"2026072315343652000_ref194","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.ms.24.080194.001315","article-title":"Carbon nanotubes","volume":"24","author":"Ebbesen","year":"1994","journal-title":"Annu Rev Mater Sci"},{"key":"2026072315343652000_ref195","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ijpharm.2015.08.087","article-title":"Gamma-aminobutyric acid loaded halloysite nanotubes and in vitro-in vivo evaluation for brain delivery","volume":"495","author":"K\u0131r\u0131ml\u0131o\u011flu","year":"2015","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/7\/rgag077\/69887060\/rgag077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/7\/rgag077\/69887060\/rgag077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:34:50Z","timestamp":1784835290000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgag077\/8740766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":237,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgag077","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"rgag077"}}